19
Mon, Apr

johnson & johnson

  • This week, health care providers began administering the first doses of Johnson & Johnson's COVID-19 vaccine in the U.S. — the third vaccine authorized by the Food and Drug Administration to help stop the coronavirus pandemic.

  • The one-dose option worked better in the U.S. — 72% effective against moderate to severe COVID-19 — compared with 66% in Latin America and 57% in South Africa, where a more contagious mutant virus is spreading.

    Johnson & Johnson asked U.S. regulators Thursday to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies.

Sign up via our free email subscription service to receive notifications when new information is available.